soVIRIP is a virus inhibitory peptide with an IC50 of 1.2 µM for HIV-1 . soVIRIP binds to the HIV-1 GP41 fusion peptide and inhibits viral fusion and entry into host cells. soVIRIP has broad-spectrum anti-HIV-1 activities with nontoxicity in zebrafish models. soVIRIP can used for viral infections research[1].
Molecular Weight:
1105.33
Formula:
C56H84N10O13
Target:
HIV
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted